Besifovir clinical trials
Also written LB80380.
How each study uses besifovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2004 (1)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses besifovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside AnaloguesCompletedPhase 3IlDong Pharmaceutical Co LtdNCT02792088Written as Besifovir 150mgHow we know
- Phase 3 and Extensional Study of BesifovirStatus unknownPhase 3IlDong Pharmaceutical Co LtdNCT01937806Written as besifovir 150mgHow we know
- A Food Effect Study of Besifovir in Healthy SubjectsCompletedPhase 4IlDong Pharmaceutical Co LtdNCT03885778Written as Besifovir dipivoxilHow we know
- Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty LiverStatus unknownPhase 4IlDong Pharmaceutical Co LtdNCT03604016Written as Besifovir dipivoxilHow we know
- Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BCompletedPhase 2LG Life SciencesNCT01026610Written as LB80380 90 mgHow we know
- Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BStatus unknownPhase 2LG Life SciencesNCT01242787Written as LB80380How we know
- Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis BCompletedPhase 1/2LG Life SciencesNCT00895596Written as LB80380How we know
As the comparator · 1 — what is tested is compared with besifovir
Codes
What other systems call besifovir · ClinicalTrials.gg INT004660
- UNII (FDA) 4PLG22CQUUBESIFOVIRConfirmed FDA, Wikidata
- Wikidata Q27260336besifovirConfirmed FDA, Wikidata
- NCI Thesaurus C166775BesifovirOne source FDA
- DrugBank DB15671One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4PLG22CQUU | BESIFOVIR | Confirmed FDA, Wikidata |
| Wikidata | Q27260336 | besifovir | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166775 | Besifovir | One source FDA |
| DrugBank | DB15671 | — | One source Wikidata |
Also registered as besifovir dipivoxil (UNII S9I9P4J8IU).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.